Search results for: “astrazeneca”
-
AstraZeneca complete acquisition of Alexion Pharmaceuticals
•
LONDON, UK: AstraZeneca today completed the acquisition of Alexion Pharmaceuticals Inc. The closing of the acquisition marks the…
-
Pakistan receives 1.23 million doses of AstraZeneca vaccine
•
ISLAMABAD: Pakistan today received 1.236 million doses of COVID-19 Vaccine AstraZeneca through COVAX. COVAX, co-led by the Coalition for Epidemic…
-
AstraZeneca’s acquisition of Alexion cleared by European Commission
•
LONDON, UK: AstraZeneca‘s proposed acquisition of Alexion Pharmaceuticals Inc. has achieved an important step towards completion by having…
-
AstraZeneca appoints Aradhana Sarin as new Chief Financial Officer
•
LONDON, UK: AstraZeneca PLC has appointed Aradhana Sarin as an Executive Director and Chief Financial Officer, conditional upon…
-
AstraZeneca COVID-19 vaccine Vaxzevria authorised for emergency use in Japan
•
LONDON: AstraZeneca‘s COVID-19 vaccine, Vaxzevria, formerly AZD1222, has been granted a special approval for emergency use in Japan…
-
AstraZeneca shareholders vote in favour of Alexion acquisition
•
LONDON: A requisite majority of AstraZeneca (LON: AZN) shareholders has approved the proposal to acquire the entire common…
-
AstraZeneca US vaccine trial met primary endpoint
•
LONDON: The AstraZeneca US Phase III trial of AZD1222 demonstrated statistically significant vaccine efficacy of 79% at preventing…
-
AstraZeneca notifies non-executive board changes
•
LONDON: AstraZeneca PLC announced today that Non-Executive Directors Geneviève Berger and Graham Chipchase intend to retire from the…
-
AstraZeneca agrees to divest Viela shareholding for upto $780mn
•
STOCKHOLM: AstraZeneca Plc has agreed, subject to certain limited exceptions, to divest its 26.7% ownership in Viela Bio…
-
COVID-19 Vaccine AstraZeneca authorised for use in the EU
•
LONDON: AstraZeneca‘s COVID-19 vaccine has been granted a conditional marketing authorisation (CMA) in the European Union (EU) for…
-
AstraZeneca’s Imfinzi approved in the European Union and the UK
•
LONDON: AstraZeneca‘s Imfinzi (durvalumab) has been approved in the European Union and the UK for an additional dosing…
-
AstraZeneca completes Atacand divestment to Cheplapharm in more than 70 countries
•
LONDON, UK: AstraZeneca has completed the divestment of commercial rights to Atacand (candesartan cilexetil) and Atacand Plus (a…
Stay Informed with the Latest News and Updates
- Contact Us
- London Stock Exchange
- Singapore Exchange
- Canadian Exchange
- Australian Exchange
- Oslo Bourse
- PSX
- Ratings
- Euronext
- MENA
- Nasdaq Nordic
- Wire
- Business & Finance
- Gadget Reviews
- About Us: A Comprehensive Financial News Database
All news and articles on NewsnReleases are based on press releases, corporate announcements and analysts’ reports issued to London Stock Exchange (LSE), Euronext, Singapore Exchange (SGX), Japan Stock Exchange (JPX), Dubai Financial Market (DFM), Saudi Stock Exchange (Tadawul), Qatar Stock Exchange (QSE), BSEIndia, Australia Stock Exchange etc.